ClearPoint Neuro Inc (CLPT) USD0.01

Sell:$13.77Buy:$15.80$0.41 (2.87%)

Prices delayed by at least 15 minutes
Sell:$13.77
Buy:$15.80
Change:$0.41 (2.87%)
Prices delayed by at least 15 minutes
Sell:$13.77
Buy:$15.80
Change:$0.41 (2.87%)
Prices delayed by at least 15 minutes

Company Information

About this company

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Key people

Joseph Michael Burnett
President, Chief Executive Officer, Director
Danilo D' Alessandro
Chief Financial Officer
Mazin Sabra
Chief Operating Officer
Jeremy L. Stigall
Chief Business Officer
R. John Fletcher
Independent Chairman of the Board
Lynnette C. Fallon
Independent Director
Pascal E.R. Girin
Independent Director
B. Kristine Johnson
Independent Director
Matthew B. Klein
Independent Director
Click to see more

Key facts

  • EPIC
    CLPT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US18507C1036
  • Market cap
    $370.73m
  • Employees
    115
  • Shares in issue
    27.98m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.